Canine glaucoma

Glaucoma Epidemiology Forecasts to 2030: 10 Year Forecasts, 7MM Coverage, Total Prevalent Cases and Glaucoma Patients by Age Group - ResearchAndMarkets.com

Retrieved on: 
Friday, July 30, 2021

The total diagnosed prevalent population of Glaucoma in the 7MM was 10,104,188 in 2020 , which is expected to increase in the forecast period.

Key Points: 
  • The total diagnosed prevalent population of Glaucoma in the 7MM was 10,104,188 in 2020 , which is expected to increase in the forecast period.
  • Among the European five countries, Germany had the highest diagnosed prevalent population of Glaucoma with 1,042,465 cases, followed by Italy and France in 2020.
  • Among the major types of Glaucoma, i.e., open-angle and close-angle glaucoma, the former one accounts for a higher number of diagnosed Glaucoma cases.
  • The report provides the segmentation of the disease epidemiology for 7MM by Total Diagnosed Prevalence of Glaucoma, Type-specific Diagnosed Prevalent Population of Glaucoma, Gender-specific Diagnosed Prevalence of Glaucoma, Age-specific Diagnosed Prevalence of Glaucoma, Type-specific Diagnosed Prevalence of Open-Angle Glaucoma.

Global Glaucoma Disease Insights and Market Forecasts to 2026 Featuring Novartis, Allergan, Pfizer, Santen Pharmaceutical, Akorn, Aerie Pharmaceuticals, & AbbVie - ResearchAndMarkets.com

Retrieved on: 
Monday, December 14, 2020

The "Glaucoma - Disease Insights and Market Forecasts to 2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Glaucoma - Disease Insights and Market Forecasts to 2026" report has been added to ResearchAndMarkets.com's offering.
  • This section of the report gives the overview of Glaucoma disease indication in detail.
  • The section highlights the basic definition, causes and symptoms of disease and details the types of Glaucoma disease.
  • Further details on the profile of Glaucoma patients, Symptoms experienced by the patients, and disease progression in patients are outlined in the report.

Merck Manuals Shares Key Information on Detecting and Treating Glaucoma

Retrieved on: 
Friday, August 14, 2020

Glaucoma is defined as progressive optic nerve damage often associated with increased eye pressure that causes irreversible loss of vision.

Key Points: 
  • Glaucoma is defined as progressive optic nerve damage often associated with increased eye pressure that causes irreversible loss of vision.
  • There are many different types of glaucoma, all with different risk factors and potential treatments.
  • Dr. Rhee compares glaucoma to high blood pressure in that there are no outward symptoms of the condition early on.
  • For more information, visit www.merck.com and connect with us on Twitter , Facebook , Instagram , YouTube and LinkedIn .

CHA Hollywood Presbyterian Medical Center Eye Disease Expert Dr. Rohit Varma Performs First ClearPath Glaucoma Surgery in L.A.

Retrieved on: 
Thursday, September 5, 2019

The procedure, called tube-shunt surgery, lowers the pressure inside the eye by placing a flexible tube with an attached silicone plate in the eye to help fluid drain.

Key Points: 
  • The procedure, called tube-shunt surgery, lowers the pressure inside the eye by placing a flexible tube with an attached silicone plate in the eye to help fluid drain.
  • Glaucoma is the leading cause of irreversible vision loss and blindness in the world, and tube-shunt surgery can preserve vision for patients with glaucoma by lowering pressure in the eye, Dr. Varma said.
  • Founded by world-renowned ophthalmologist Rohit Varma, MD, MPH, SCEI is located in Los Angeles at CHA Hollywood Presbyterian Medical Center.
  • CHA Hollywood Presbyterian Medical Center (CHA HPMC) is a nationally recognized acute care facility that has cared for Hollywood and its surrounding communities since 1924.

Wills Eye Hospital Research Suggests Glaucoma Patients May Be at Higher Risk of Motor Vehicle Accidents than those of Similar Age

Retrieved on: 
Wednesday, May 22, 2019

The study followed a group of 161 patients with an average age of 64 with moderate open angle glaucoma in at least one eye over 4 years.

Key Points: 
  • The study followed a group of 161 patients with an average age of 64 with moderate open angle glaucoma in at least one eye over 4 years.
  • Each year, patients were asked if they were a driver in any motor vehicle accidents during the previous year.
  • While further research is needed, these findings suggest that:
    An impaired visual field in either eye was found to be an independent risk factor for motor vehicle accidents in patients with moderate glaucoma.
  • Identifying individuals at risk for accidents may help prevent accidents by educating providers and patients with glaucoma regarding their safety and fitness to drive.

Global Glaucoma treatment Market Forecast to 2023 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, January 15, 2019

The "Global Glaucoma treatment Market Research and Forecast 2018-2023" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Glaucoma treatment Market Research and Forecast 2018-2023" report has been added to ResearchAndMarkets.com's offering.
  • The global glaucoma treatment market is emerging with a rapid speed due to some of the major factors such as growing incidences of glaucoma diseases across the globe.
  • The global glaucoma treatment market is studied on the basis of these segments: products, disease indication, end user and drug class.
  • On the basis of disease indication, the market is sub-segmented as closed angle glaucoma, open angle glaucoma, congenital glaucoma and secondary glaucoma.